Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
Cells. 2021 May 14;10(5):1207. doi: 10.3390/cells10051207.
Autophagy is a lysosomal-dependent degradative mechanism essential in maintaining cellular homeostasis, but it is also considered an ancient form of innate eukaryotic fighting against invading microorganisms. Mounting evidence has shown that HIV-1 is a critical target of autophagy that plays a role in HIV-1 replication and disease progression. In a special subset of HIV-1-infected patients that spontaneously and durably maintain extremely low viral replication, namely, long-term nonprogressors (LTNP), the resistance to HIV-1-induced pathogenesis is accompanied, in vivo, by a significant increase in the autophagic activity in peripheral blood mononuclear cells. Recently, a new player in the battle of autophagy against HIV-1 has been identified, namely, tripartite motif protein 5α (TRIM5α). In vitro data demonstrated that TRIM5α directly recognizes HIV-1 and targets it for autophagic destruction, thus protecting cells against HIV-1 infection. In this paper, we analyzed the involvement of this factor in the control of HIV-1 infection through autophagy, in vivo, in LTNP. The results obtained showed significantly higher levels of TRIM5α expression in cells from LTNP with respect to HIV-1-infected normal progressor patients. Interestingly, the colocalization of TRIM5α and HIV-1 proteins in autophagic vacuoles in LTNP cells suggested the participation of TRIM5α in the autophagy containment of HIV-1 in LTNP. Altogether, our results point to a protective role of TRIM5α in the successful control of the chronic viral infection in HIV-1-controllers through the autophagy mechanism. In our opinion, these findings could be relevant in fighting against HIV-1 disease, because autophagy inducers might be employed in combination with antiretroviral drugs.
自噬是一种溶酶体依赖性的降解机制,对于维持细胞内稳态至关重要,但它也被认为是一种古老的真核生物抵御入侵微生物的形式。越来越多的证据表明,HIV-1 是自噬的一个关键靶点,在 HIV-1 复制和疾病进展中发挥作用。在一组特殊的 HIV-1 感染患者中,他们自发地、持久地维持极低的病毒复制,即长期非进展者(LTNP),对 HIV-1 诱导的发病机制的抵抗力伴随着外周血单个核细胞自噬活性的显著增加。最近,自噬对抗 HIV-1 的战斗中出现了一个新的参与者,即三结构域蛋白 5α(TRIM5α)。体外数据表明,TRIM5α 直接识别 HIV-1 并将其靶向自噬破坏,从而保护细胞免受 HIV-1 感染。在本文中,我们分析了该因子在 LTNP 中通过自噬控制 HIV-1 感染的体内参与情况。结果表明,LTNP 细胞中的 TRIM5α 表达水平明显高于 HIV-1 感染的正常进展患者。有趣的是,TRIM5α 和 HIV-1 蛋白在 LTNP 细胞自噬空泡中的共定位表明 TRIM5α 参与了 LTNP 中 HIV-1 的自噬控制。总之,我们的结果表明,TRIM5α 通过自噬机制在成功控制 HIV-1 感染者的慢性病毒感染中发挥保护作用。在我们看来,这些发现可能与对抗 HIV-1 疾病有关,因为可以使用自噬诱导剂与抗逆转录病毒药物联合使用。